Trials / Completed
CompletedNCT01488786
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
A Study to Evaluate the Safety and Efficacy of the BrainPort® Vision Device in Subjects Who Are Blind
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Wicab · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety of the BrainPort vision device and to demonstrate improved object recognition and word identification and ambulation with use of the BrainPort vision device in subjects who are medically documented as blind, with acuity of 20/ 5000 or worse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BrainPort Vision Device | 2-3 days of training (10 hours) followed by minimum in-home use 300 minutes per month for 12 months. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2011-12-08
- Last updated
- 2013-08-09
Locations
7 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01488786. Inclusion in this directory is not an endorsement.